Business news in brief
GlaxoSmithKline P.L.C. and Valeant Pharmaceuticals International say they may have to wait an extra three months for the U.S. regulatory review of their potential epilepsy treatment ezogabine.
Read more on The Philadelphia Inquirer
Calendar
Submissions for the Community Calendar are required 10 days preceding the date of publication. Send to: Pioneer Press, 3701 W. Lake Ave., Glenview IL 60026. Information may be faxed to (847) 486-7495 or e-mailed to mbottari@pioneerlocal.com.
Read more on Norridge-Harwood Heights News
Community Calendar
The Edison-Norwood Times Review welcomes items for our Community Calendar. Items must be received a minimum of two weeks prior to publication, but earlier is better. Items are printed as space allows, and publication is not guaranteed. E-mail items to mbottari@pioneerlocal.com; fax to (847) 486-7495; or mail to: Pioneer Press, 3701 W. Lake Ave., Glenview IL 60026.
Read more on Edison-Norwood Times Review
